Entries of Ziepert, M. on the publication server

Croci, G. A., Au-Yeung, R. K. H., Reinke, S., Staiger, A. M., Koch, K., Oschlies, I., Richter, J., Poeschel, V., Held, G., Loeffler, M., Trümper, L., Rosenwald, A., Ott, G., Spang, Rainer, Altmann, B., Ziepert, M. and Klapper, W. (2021) SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status. Annals of Oncology. Fulltext not available.

Staiger, A. M., Altenbuchinger, Michael, Ziepert, M., Kohler, Christian, Horn, H., Huttner, Michael , Huttl, K. S., Glehr, Gunther , Klapper, W., Szczepanowski, M., Richter, J., Stein, H., Feller, A. C., Moller, P., Hansmann, M. L., Poeschel, V., Held, G., Loeffler, M., Schmitz, N., Trumper, L., Pukrop, T., Rosenwald, A., Ott, G., Spang, Rainer , Emed Demonstrator Project, and German High Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL), (2019) A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL. Leukemia 34, pp. 543-552. Fulltext not available.

Ziemer, M., Haeusermann, P., Janin, A., Massi, D., Ziepert, M., Wolff, D., Greinix, H. and Hillen, U. (2014) Histopathological diagnosis of graft‐versus‐host disease of the skin – an interobserver comparison. Journal of the European Academy of Dermatology and Venereology 28 (7), pp. 915-924. Fulltext not available.